Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

undersøges !!

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of antidepressants on brain volume

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nyt studie viser, at motion beskytter mod depression

    Research output: Contribution to journalContribution to newspaper - Comment/debateCommunication

  3. Forebyggelse og behandling af cytomegalovirusinfektion hos gravide og nyfødte

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Groin hernia in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Boganmeldelse: Min mor var besat

    Research output: Contribution to journalContribution to newspaper - ReviewCommunication

  1. Peripheral memory T cells specific for Arginase-1

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Real-world evidence to guide healthcare policies in oncology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Line Thing Simonsen
  • Anne Mette Sjørslev Schmidt
  • Trine Heide Øllegaard
  • Inge Marie Svane
  • Lars Bastholt
  • Adam Andrzej Luczak
  • Henrik Schmidt
View graph of relations

Melanoma has a high propensity to form brain metastases, and in this review, we discuss the treatment options for brain metastases. These have previously been sparse, but with the introduction of targeted therapy and checkpoint inhibitors, studies including patients with brain metastases have been published. Recent studies investigating combination of either dabrafenib and trametinib or ipilimumab and nivolumab have proved promising. Based on phase II studies, the most effective treatment for patients with asymptomatic brain metastases seems to be ipilimumab and nivolumab. Symptomatic brain metastases are presently being further investigated.

Translated title of the contributionImmunotherapy for patients with malignant melanoma and brain metastases
Original languageDanish
JournalUgeskrift for Laeger
Volume181
Issue number24
ISSN0041-5782
Publication statusPublished - 10 Jun 2019

ID: 57728547